BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barry S, Breen R, Lipman M, Johnson M, Janossy G. Impaired antigen-specific CD4(+) T lymphocyte responses in cavitary tuberculosis. Tuberculosis (Edinb) 2009;89:48-53. [PMID: 18799355 DOI: 10.1016/j.tube.2008.07.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Pacl HT, Chinta KC, Reddy VP, Nadeem S, Sevalkar RR, Nargan K, Lumamba K, Naidoo T, Glasgow JN, Agarwal A, Steyn AJC. NAD(H) homeostasis is essential for host protection mediated by glycolytic myeloid cells in tuberculosis.. [DOI: 10.1101/2022.09.11.507472] [Reference Citation Analysis]
2 Singh S, Allwood BW, Chiyaka TL, Kleyhans L, Naidoo CC, Moodley S, Theron G, Segal LN. Immunologic and imaging signatures in post tuberculosis lung disease. Tuberculosis (Edinb) 2022;136:102244. [PMID: 36007338 DOI: 10.1016/j.tube.2022.102244] [Reference Citation Analysis]
3 Lo CY, Huang YC, Huang HY, Chung FT, Lin CW, Chung KF, Wang CH. Increased Th1 Cells with Disease Resolution of Active Pulmonary Tuberculosis in Non-Atopic Patients. Biomedicines 2021;9:724. [PMID: 34202662 DOI: 10.3390/biomedicines9070724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kolloli A, Kumar R, Singh P, Narang A, Kaplan G, Sigal A, Subbian S. Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology.. [DOI: 10.1101/2021.05.19.444830] [Reference Citation Analysis]
5 Chinta KC, Pacl HT, Agarwal A, Steyn AJC. Heme Oxygenase-1 as a Pharmacological Target for Host-Directed Therapy to Limit Tuberculosis Associated Immunopathology. Antioxidants (Basel) 2021;10:177. [PMID: 33530574 DOI: 10.3390/antiox10020177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Oyer RA, Schlossberg D. Hematologic Complications of Tuberculosis. Tuberculosis and Nontuberculous Mycobacterial Infections 2021. [DOI: 10.1128/9781555817138.ch29] [Reference Citation Analysis]
7 Pellegrini JM, Sabbione F, Morelli MP, Tateosian NL, Castello FA, Amiano NO, Palmero D, Levi A, Ciallella L, Colombo MI, Trevani AS, García VE. Neutrophil autophagy during human active tuberculosis is modulated by SLAMF1. Autophagy 2020;:1-10. [PMID: 32954947 DOI: 10.1080/15548627.2020.1825273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
8 Gergert VJ, Averbakh MM, Ergeshov AE. [Immunological aspects of tuberculosis pathogenesis]. Ter Arkh 2019;91:90-7. [PMID: 32598618 DOI: 10.26442/00403660.2019.11.000262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Khan SR, Manialawy Y, Siraki AG. Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action. Br J Pharmacol 2019;176:4599-608. [PMID: 31517993 DOI: 10.1111/bph.14867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
10 Young C, Ahlers P, Hiemstra AM, Loxton AG, Gutschmidt A, Malherbe ST, Walzl G, Du Plessis N; the SU-IRG consortium. Performance and immune characteristics of bronchoalveolar lavage by research bronchoscopy in pulmonary tuberculosis and other lung diseases in the Western Cape, South Africa. transl med commun 2019;4. [DOI: 10.1186/s41231-019-0039-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
11 Shi W, Wu J, Tan Q, Hu CM, Zhang X, Pan HQ, Yang Z, He MY, Yu M, Zhang B, Xie WP, Wang H. Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients. Infect Drug Resist 2019;12:1265-76. [PMID: 31190914 DOI: 10.2147/IDR.S202369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Cavalcanti-Neto MP, Prado RQ, Piñeros AR, Sérgio CA, Bertolini TB, Gembre AF, Ramos SG, Bonato VL. Improvement of the resistance against early Mycobacterium tuberculosis-infection in the absence of PI3Kγ enzyme is associated with increase of CD4+IL-17+ cells and neutrophils. Tuberculosis (Edinb) 2018;113:1-9. [PMID: 30514491 DOI: 10.1016/j.tube.2018.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lowe DM, Demaret J, Bangani N, Nakiwala JK, Goliath R, Wilkinson KA, Wilkinson RJ, Martineau AR. Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood. Front Immunol 2018;9:903. [PMID: 29755473 DOI: 10.3389/fimmu.2018.00903] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
14 Cui JY, Liang HW, Pan XL, Li D, Jiao N, Liu YH, Fu J, He XY, Sun GX, Zhang CL, Zhao CH, Li DH, Dai EY, Zen K, Zhang FM, Zhang CY, Chen X, Ling H. Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals. PLoS One 2017;12:e0184113. [PMID: 28910318 DOI: 10.1371/journal.pone.0184113] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
15 Balepur SS, Schlossberg D. Hematologic Complications of Tuberculosis. Microbiol Spectr 2016;4. [PMID: 28084210 DOI: 10.1128/microbiolspec.TNMI7-0004-2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lyadova IV. Neutrophils in Tuberculosis: Heterogeneity Shapes the Way? Mediators Inflamm 2017;2017:8619307. [PMID: 28626346 DOI: 10.1155/2017/8619307] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 9.5] [Reference Citation Analysis]
17 Balepur SS, Schlossberg D. Hematologic Complications of Tuberculosis. Tuberculosis and Nontuberculous Mycobacterial Infections 2017. [DOI: 10.1128/9781555819866.ch31] [Reference Citation Analysis]
18 Wang J, Dai Y, Liu J, Yin Y, Pei H. MTB-specific lymphocyte responses are impaired in tuberculosis patients with pulmonary cavities. Eur J Med Res 2017;22:4. [PMID: 28122644 DOI: 10.1186/s40001-016-0242-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
19 Huang Q, Yin Y, Kuai S, Yan Y, Liu J, Zhang Y, Shan Z, Gu L, Pei H, Wang J. The value of initial cavitation to predict re-treatment with pulmonary tuberculosis. Eur J Med Res 2016;21:20. [PMID: 27154410 DOI: 10.1186/s40001-016-0214-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
20 Dorhoi A, Kaufmann SH. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin Immunopathol. 2016;38:153-166. [PMID: 26438324 DOI: 10.1007/s00281-015-0531-3] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 11.3] [Reference Citation Analysis]
21 Hasan Z, Rao N, Salahuddin N, Islam M, Ashraf M, Rottenberg ME, Hussain R. Mycobacterium tuberculosis Sonicate-Induced IFNγ, CXCL10 and IL10 can Differentiate Severity in Tuberculosis. Scand J Immunol 2012;75:220-6. [PMID: 21958213 DOI: 10.1111/j.1365-3083.2011.02642.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
22 Fan L, Xiao H, Mai G, Su B, Ernst J, Hu Z. Impaired M. tuberculosis Antigen-Specific IFN-γ Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary Tuberculosis. PLoS One 2015;10:e0127087. [PMID: 26018190 DOI: 10.1371/journal.pone.0127087] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
23 Tsiganov EN, Verbina EM, Radaeva TV, Sosunov VV, Kosmiadi GA, Nikitina IY, Lyadova IV. Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice. J Immunol 2014;192:4718-27. [PMID: 24711621 DOI: 10.4049/jimmunol.1301365] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 8.7] [Reference Citation Analysis]
24 Masood KI, Rottenberg ME, Carow B, Rao N, Ashraf M, Hussain R, Hasan Z. SOCS1 gene expression is increased in severe pulmonary tuberculosis. Scand J Immunol 2012;76:398-404. [PMID: 22670716 DOI: 10.1111/j.1365-3083.2012.02731.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
25 Fan L, Xiao HP, Hu ZY, Ernst JD. Variation of Mycobacterium tuberculosis antigen-specific IFN-γ and IL-17 responses in healthy tuberculin skin test (TST)-positive human subjects. PLoS One 2012;7:e42716. [PMID: 22880090 DOI: 10.1371/journal.pone.0042716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
26 Kunnath-Velayudhan S, Gennaro ML. Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev 2011;24:792-805. [PMID: 21976609 DOI: 10.1128/CMR.00014-11] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
27 Sanchez J, Tomás L, Ortega N, Buendía A, del Rio L, Salinas J, Bezos J, Caro M, Navarro J. Microscopical and Immunological Features of Tuberculoid Granulomata and Cavitary Pulmonary Tuberculosis in Naturally Infected Goats. Journal of Comparative Pathology 2011;145:107-17. [DOI: 10.1016/j.jcpa.2010.12.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
28 Kalsdorf B, Scriba TJ, Wood K, Day CL, Dheda K, Dawson R, Hanekom WA, Lange C, Wilkinson RJ. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am J Respir Crit Care Med 2009;180:1262-70. [PMID: 19797156 DOI: 10.1164/rccm.200907-1011OC] [Cited by in Crossref: 112] [Cited by in F6Publishing: 120] [Article Influence: 8.0] [Reference Citation Analysis]